Thursday, October 15, 2015 | 8:00 AM - 5:00 PM
Speakers: Jonathan Braun (University of CaliforniaLos Angeles), Rudolph Clerval (Enterome), Stanislav Dusko Ehrlich (King's College London), Michael A. Fischbach (University of California, San Francisco), Andy Goodman (Yale School of Medicine), Randy Longman (Weill Cornell Medical College), Sarkis Mazmanian (California Institute of Technology), Paul O'Toole (University College Cork), R. Balfour Sartor (University of North Carolina School of Medicine)
In the human colon, the microbiome forms one of the densest bacterial ecosystems known in nature. This symposium will highlight recent research innovations and therapeutic applications from the microbiome with a focus on gut health.
Tuesday, October 27, 2015 | 8:00 AM - 5:00 PM
Speakers: Andras J. Bauer (Boehringer Ingelheim USA), Michael R. Jackson (Sanford Burnham Prebys Medical Discovery Institute), Jonathan A. Lee (Eli Lilly), Martin Main (AstraZeneca), Friedrich Metzger (F. Hoffmann-La Roche Ltd), Bruce A. Posner (University of Texas, Southwestern Medical Center), Aravind Subramanian (Broad Institute), Giulio Superti-Furga (Austrian Academy of Sciences), Susanne Swalley (Novartis Institutes for Biomedical Research)
This symposium aims to deepen our understanding of phenotypic drug discovery and to foster the exchange of ideas between industry-based and academic research scientists.
October 28 - 29, 2015
This 2-day colloquium will explore challenges surrounding pre-approval access to investigational medicines in a series of debates featuring prominent representatives of governments, pharmaceutical companies, patient groups, NGOs, and foundations.
Tuesday, November 3, 2015 | 6:00 PM - 8:30 PM
Keynote Speaker: Jaime Rubin (Columbia University)
Join Science Alliance and NYWiSTEM for the Grantsmanship workshop. During this evening seminar, Dr. Jaime Rubin will focus on best practices for effective grantsmanship, specifically applied to the NIH K99/R00 career transition grant application.
Tuesday, December 8, 2015 | 8:30 AM - 5:00 PM
Speakers: David D'Alessio (University of Cincinnati), Richard DiMarchi (Indiana University), Matthew Hayes (Perelman School of Medicine, University of Pennsylvania), George Holz (State University of New York), Lotte Knudsen (Novo Nordisk), Patrick Sexton (Monash University), Konrad Talbot (Cedars-Sinai Medical Center), Beat Jucker (GlaxoSmithKline)
GLP-1 receptor agonists have improved treatment options in type 2 diabetes, although realizing their promise in other areas remains challenging. This symposium highlights preclinical and clinical breakthroughs and opportunities for drug development.
For multimedia from recent Academy webinars, please view the Academy's eBriefings catalog.